• Center for Biosimilars
AJMC
AJMC
Stakeholders
Topics
Institute for Value-Based Medicine
About AJMC
News
Media
Conferences
Journals
Compendia
Events
Resources
Subscribe
  • About Us
  • Advertise
  • Contact
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2021 MJH Life Sciences and AJMC. All rights reserved.

Stakeholders
  • Academia
  • Employers
  • Health System
  • Payers
  • Providers
Topics
  • Clinical
  • Healthcare Cost
  • Healthcare Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Institute for Value-Based Medicine
  • All Coverage
  • Event Coverage
  • Interviews
  • News
About AJMC
  • AJMC Journals
  • Anniversary
  • Author Forms
  • Authors
  • Nominate a Rising Leader
  • About Us
  • Advertise
  • Contact
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.

Formulary Central

Navigating to Formulary Central

The information contained in this section of the site is intended for formulary decision makers only. Click "OK" if you are a formulary decision maker.

Clinical

ONIVYDE® (irinotecan liposome injection) Formulary Central
Pulmonary Arterial Hypertension Formulary Central
ARIKAYCE ® (amikacin liposome inhalation suspension) Formulary Central
SOMATULINE® DEPOT (lanreotide) Formulary Central
Sickle Cell Disease: Current Treatment and Emerging Therapies Formulary Central
INQOVI® (decitabine and cedazuridine) Formulary Central